Tuesday, July 26, 2011

BayBio COO leaves after 16 months, lands in D.C.

Jeremy Leffler has quietly returned to Washington, D.C., after just 16 months as chief operating officer and CEO-to-be at the life sciences trade group BayBio.
A self-described “political junkie,” Leffler is the new director of federal policy for drug developer Sanofi-Aventis. He had spent eight years in the nation’s capital, including four as manager of federal public policy with Eli Lilly and Co., before taking the BayBio post in February 2010.

No comments:

Post a Comment